SpyGlass Pharma (SGP)

• Market cap: $744M
• 1 day: 2.82%
• 5 days: 12.88%
• 1 month: 21.51%
• 3 months: -4.75%
• 6 months: -15.68%
• Year to date: -15.68%
• 1 year: -15.68%
• 5 years: -15.68%
• 10 years: -15.68%
• Sector: Healthcare
• Industry: Biotechnology

About: SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Employees: 65